In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
Charles E. Argoff, MD, Professor of Neurology and Director of the Comprehensive Pain Center, Albany Medical Center, describes new guidelines for pain management in geriatrics. The most reasonable…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Adding the anti-VEGF monoclonal antibody bevacizumab to state-of-the-art adjuvant chemotherapy for stage II or III colon cancer does not improve disease-free survival, according…
NEW YORK (Reuters Health) – Rofecoxib used as adjuvant therapy does not improve survival or reduce recurrences in patients who have undergone surgery for colorectal cancer, according to…
NEW YORK (Reuters Health) – Children 1 to 3 years old with influenza benefit substantially from treatment with oseltamivir when it’s given within 24 hours of symptom onset,…
NEW YORK (Reuters Health) – Adding interferon alpha-2b and megadose vitamins to treatment with intravesical BCG does not improve outcomes in patients with non-muscle invasive bladder cancer. In…
NEW YORK (Reuters Health) – When gynecologic surgery is performed laparoscopically, the occurrence of thromboembolism is quite rare, even in patients with gynecologic malignancy, researchers report in the…
NEW YORK (Reuters Health) – Men whose baseline PSA is less than 2.0 ng/mL are unlikely to benefit from further screening for prostate cancer, according to findings reported…
NEW YORK (Reuters Health) – Patients with bipolar I disorder who haven’t been treated with a mood stabilizer and experience an episode of major depression may respond well…
